摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2,5-dimethoxy-phenyl)-1-pyridin-4-yl-propenone | 851663-32-6

中文名称
——
中文别名
——
英文名称
3-(2,5-dimethoxy-phenyl)-1-pyridin-4-yl-propenone
英文别名
3-(2,5-Dimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one;3-(2,5-dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one
3-(2,5-dimethoxy-phenyl)-1-pyridin-4-yl-propenone化学式
CAS
851663-32-6
化学式
C16H15NO3
mdl
——
分子量
269.3
InChiKey
VUKHLWOOQUNJMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    128-130 °C(Solv: methanol (67-56-1); ethanol (64-17-5))
  • 沸点:
    448.6±45.0 °C(Predicted)
  • 密度:
    1.165±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    48.4
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:38c7c3f0f1b022dc5f90aaebc376c2a6
查看

反应信息

  • 作为反应物:
    描述:
    3-(2,5-dimethoxy-phenyl)-1-pyridin-4-yl-propenone一水合肼 作用下, 反应 0.05h, 以82%的产率得到4-[5-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-pyridine
    参考文献:
    名称:
    Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives
    摘要:
    Pyrazole derivatives IIa-l have been synthesized by condensation of chalcones Ia-f with hydrazine hydrate and phenyl hydrazine under microwave irradiation in good yields. Oxadiazole derivatives IVa-f have been synthesized by condensation of N'-hydroxypicolinamidine, N'-hydroxy isonicotinamidine, N'-hydroxypyrazine-2-carboxamidine with 2,5 dimethoxybenzaldehyde and 3-methoxy-4-hydroxy benzaldehyde, respectively. Structures assigned to IIa-l and IVa-f are fully supported by correct spectral and analytical data. All compounds (IIa-l & IVa-f) have been screened for anti-inflammatory and anticancer activities. Compounds IIj, IIk, and IVb exhibited good anti-inflammatory activity, while, IIa, c, j, and IVd showed better anticancer activity against four and three cancer cell lines, respectively.
    DOI:
    10.1007/s00044-011-9850-7
  • 作为产物:
    描述:
    4-乙酰吡啶2,5-二甲氧基苯甲醛sodium hydroxide 作用下, 以 为溶剂, 以67%的产率得到3-(2,5-dimethoxy-phenyl)-1-pyridin-4-yl-propenone
    参考文献:
    名称:
    4-吡啶基-6-芳基-2-取代的氨基嘧啶类化合物的合成作为一类新的抗疟药。
    摘要:
    合成了一系列的2,4,6-三取代的嘧啶并评估了它们对恶性疟原虫的体外抗疟活性。在合成的18种化合物中,有14种化合物的MIC在0.25-2 microg / mL范围内。这些化合物在体外的活性是乙胺嘧啶的几倍。
    DOI:
    10.1016/j.bmc.2005.06.052
点击查看最新优质反应信息

文献信息

  • Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives
    作者:Sham M. Sondhi、Sandeep Kumar、Nikhil Kumar、Partha Roy
    DOI:10.1007/s00044-011-9850-7
    日期:2012.10
    Pyrazole derivatives IIa-l have been synthesized by condensation of chalcones Ia-f with hydrazine hydrate and phenyl hydrazine under microwave irradiation in good yields. Oxadiazole derivatives IVa-f have been synthesized by condensation of N'-hydroxypicolinamidine, N'-hydroxy isonicotinamidine, N'-hydroxypyrazine-2-carboxamidine with 2,5 dimethoxybenzaldehyde and 3-methoxy-4-hydroxy benzaldehyde, respectively. Structures assigned to IIa-l and IVa-f are fully supported by correct spectral and analytical data. All compounds (IIa-l & IVa-f) have been screened for anti-inflammatory and anticancer activities. Compounds IIj, IIk, and IVb exhibited good anti-inflammatory activity, while, IIa, c, j, and IVd showed better anticancer activity against four and three cancer cell lines, respectively.
  • Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents
    作者:Anu Agarwal、Kumkum Srivastava、S.K. Puri、Prem M.S. Chauhan
    DOI:10.1016/j.bmc.2005.06.052
    日期:2005.11
    A series of 2,4,6-trisubstituted pyrimidines were synthesized and evaluated for their in vitro antimalarial activity against Plasmodium falciparum. Of the 18 compounds synthesized, 14 compounds showed MIC in the range of 0.25-2 microg/mL. These compounds are in vitro several fold more active than pyrimethamine.
    合成了一系列的2,4,6-三取代的嘧啶并评估了它们对恶性疟原虫的体外抗疟活性。在合成的18种化合物中,有14种化合物的MIC在0.25-2 microg / mL范围内。这些化合物在体外的活性是乙胺嘧啶的几倍。
查看更多